---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-21-009027"
form_type: "8-K"
ticker: "PASG"
cik: "0001787297"
company_name: "Passage BIO, Inc."
filed_at: "2021-07-21T23:59:59+00:00"
generated_at: "2026-06-30T03:49:23.984648+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Passage Bio appoints Simona King as CFO, effective August 23, 2021

## Summary
- Simona King, age 49, named CFO; most recently CFO of Tmunity Therapeutics (Sep 2020–Jun 2021).
- Annual base salary of $425,000, cash bonus up to 40% of base, and option for 360,000 shares.
- Options vest 1/4 after one year, then monthly over 3 years; severance includes 9–12 months salary.
- Bruce Goldsmith (CEO) serves as interim Principal Financial Officer until King's start date.

## SEC filing metadata
- accession: 0001558370-21-009027
- form_type: 8-K
- ticker: PASG
- cik: 0001787297
- company_name: Passage BIO, Inc.
- filed_at: 2021-07-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787297/000155837021009027/0001558370-21-009027-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787297/000155837021009027/tmb-20210715x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-21-009027
- JSON: https://secwatch.observer/filing/0001558370-21-009027.json
- Plain text: https://secwatch.observer/filing/0001558370-21-009027.txt

## Key facts
- Executive change
  Simona King was appointed as Chief Financial Officer at Passage BIO, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: appointed Simona King, age 49, as Chief Financial Officer, effective on or about August 23, 2021
  evidence_url: https://www.sec.gov/Archives/edgar/data/1787297/000155837021009027/0001558370-21-009027-index.htm
- Executive change
  Bruce Goldsmith was appointed as Principal Financial Officer at Passage BIO, Inc..
  - Action: appointed
  - Role: Principal Financial Officer
  source text: The Board appointed Bruce Goldsmith, Ph.D., a member of the Board and the Company’s President and Chief Executive Officer, as the Company’s Principal Financial Officer, effective immediately until the Commencement Date
  evidence_url: https://www.sec.gov/Archives/edgar/data/1787297/000155837021009027/0001558370-21-009027-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.